These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Quantitative assessment of cortical motor dysfunction by measurement of the regional cerebral blood flow. Roland PE Scand J Rehabil Med Suppl; 1980; 7():27-41. PubMed ID: 6932728 [No Abstract] [Full Text] [Related]
25. [Cerebral blood flow in hypertension]. Globus M; Melamed E; Keren A; Tzivoni D; Stern S Harefuah; 1982 Nov; 103(10):240-2. PubMed ID: 7182321 [No Abstract] [Full Text] [Related]
26. Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease. Greenamyre JT; Eller RV; Zhang Z; Ovadia A; Kurlan R; Gash DM Ann Neurol; 1994 Jun; 35(6):655-61. PubMed ID: 8210221 [TBL] [Abstract][Full Text] [Related]
27. [Quantitative determination of regional cerebral blood flow using a gamma camera]. Popova LM; Musatova IV Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(9):1290-7. PubMed ID: 7435048 [TBL] [Abstract][Full Text] [Related]
28. [Regional cerebral blood flow in patients with hypertensive intracerebral hemorrhage--patients with putaminal hemorrhage treated surgically]. Kuroda K No To Shinkei; 1982 Jun; 34(6):561-9. PubMed ID: 7115593 [No Abstract] [Full Text] [Related]
29. [Bromocriptin in Parkinson's syndrome]. Völler GW; Ulm G Med Welt; 1979 Dec; 30(51-52):1930-3. PubMed ID: 542110 [No Abstract] [Full Text] [Related]
30. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Brefel-Courbon C; Payoux P; Thalamas C; Ory F; Quelven I; Chollet F; Montastruc JL; Rascol O Mov Disord; 2005 Dec; 20(12):1557-63. PubMed ID: 16078219 [TBL] [Abstract][Full Text] [Related]
31. Variation of therapeutic response in Parkinson's disease: a retrospective study. Geminiani G; Cesana BM; Scigliano G; Soliveri P; Girotti F; Giovannini P; Caraceni T Acta Neurol Scand; 1990 May; 81(5):397-401. PubMed ID: 2375240 [TBL] [Abstract][Full Text] [Related]
32. Oral and genital pain syndromes in Parkinson's disease. Ford B; Louis ED; Greene P; Fahn S Mov Disord; 1996 Jul; 11(4):421-6. PubMed ID: 8813222 [TBL] [Abstract][Full Text] [Related]
34. Regional cerebral blood flow: normal values in healthy volunteers obtained by a 32 probes xenon 133 inhalation system. Cossu M; Cabri M; De Carli F; Montano V; Rodriguez G; Siccardi A; Traverso R; Rosadini G Boll Soc Ital Biol Sper; 1982 Jun; 58(12):766-72. PubMed ID: 7104100 [TBL] [Abstract][Full Text] [Related]
35. [Use of biperiden in delayed-release form in the treatment of Parkinson's disease and parkinsonian syndromes of various etiologies. Clinical experiments]. Puntoni U Clin Ter; 1983 Oct; 107(1):37-44. PubMed ID: 6653070 [No Abstract] [Full Text] [Related]
36. "Pure" striatonigral degeneration and Parkinson's disease: a comparative clinical study. Gouider-Khouja N; Vidailhet M; Bonnet AM; Pichon J; Agid Y Mov Disord; 1995 May; 10(3):288-94. PubMed ID: 7651445 [TBL] [Abstract][Full Text] [Related]
37. Pharmacotherapy of Parkinson's disease. Cohen MM; Scheife RT J Maine Med Assoc; 1977 Apr; 68(4):134-41, 146. PubMed ID: 845500 [No Abstract] [Full Text] [Related]
38. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa. Parkinson Study Group. Ann Neurol; 1996 Jan; 39(1):29-36. PubMed ID: 8572663 [TBL] [Abstract][Full Text] [Related]